secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2023-09-05T23:59:59+00:00
Accession:  0001558370-23-015422
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema raises $130M equity, secures $50M credit facility from SVB
----------------------------------------------------------------

- Private placement of 13,211,382 shares at $9.84/share raises ~$130M gross.
- $50M Silicon Valley Bank credit facility; $25M available at close, $25M discretionary.
- Proceeds to fund palazestrant (OP-1250) development and extend runway into 2027.
- Lock-up on shares until Phase 1b/2 data release or Dec 31, 2023.
- Investors include Paradigm BioCapital, Lightspeed, Deep Track, BVF, Cormorant, Vivo, Logos, Woodline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000155837023015422/0001558370-23-015422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000155837023015422/olma-20230905x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-015422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer